Secondary prevention of cardiovascular diseases: current state-of-art

2019-06-07

Gerd Hasenfuß

This lecture was recorded at the 4th McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, visit www.mircim.eu.

0:00

Loaded: 0%

Progress: 0%

Stream TypeLIVE

0:00

See also

What is new in the management of acute coronary syndromes A lecture by Dr Zaza Iakobishvilil, from Rabin Medical Center, Israel, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
The most frequent causes of medical errors: how to avoid them A lecture by Dr Melvin S. Blanchard, from Washington University School of Medicine in St. Louis, USA, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
How to keep patients with chronic heart failure out of hospital A lecture by Dr Harriette Van Spall, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
Low-dose ASA in stable coronary disease Should we prescribe low-dose acetylsalicylic acid (ASA) for all patients with stable coronary disease?
Adjusting exercise in patients with heart failure How to adjust the level of exercise in a patient with heart failure?
PCSK9 inhibitors in secondary prevention of MI In which patients should proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors be used in the secondary prevention of myocardial infarction (MI)?
Thrombectomy in patients with STEMI undergoing PCI In which patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) should we perform thrombectomy?

Secondary prevention of cardiovascular diseases: current state-of-art

Social Media